AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30950565 — intervention group
Group type: COMPARATOR
Intervention: GSK3008356 higher doses
Number of subjects: 104
Study 29959048 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 37
Study 29959048 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 37
Study 27092862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT) plus treatment as usual (TAU)
Number of subjects: 29
Study 27092862 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 29
Study 23510665 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV-NG
Number of subjects: 384
Study 23510665 — intervention group
Group type: COMPARATOR
Intervention: Verorab
Number of subjects: 384
Study 21327534 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 40
Study 21327534 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 40
Study 19735515 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrating gel-cream (active product)
Number of subjects: 66
Study 19735515 — intervention group
Group type: COMPARATOR
Intervention: Gel-cream without active substances (placebo)
Number of subjects: 66
Study 17317205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (6mg single dose on day 2 of FEC-100) - Primary Prophylaxis (PP)
Number of subjects: 60
Study 17317205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (6mg single dose on day 2 of FEC-100) - Secondary Prophylaxis (SP)
Number of subjects: 60
Study 15541132 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% silver nitrate
Number of subjects: 106
Study 15541132 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% povidone iodine
Number of subjects: 106
Study 15541132 — intervention group
Group type: COMPARATOR
Intervention: 50% dextrose
Number of subjects: 106
Study 11303547 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure wristband
Number of subjects: 97
Study 11303547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 9815633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate (PPS) administered orally (p.o.) at doses of 180, 270, and 400 mg/m2 t.i.d.
Number of subjects: 21
Study 9815633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate (PPS) administered orally (p.o.) at doses of 400 mg/m2 t.i.d.
Number of subjects: 21
Study 9815633 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate (PPS) administered orally (p.o.) at various doses.
Number of subjects: 21
Study 8230266 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg/d orally for 2 years
Number of subjects: 17
Study 2869951 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg bisoprolol
Number of subjects: 48
Study 2869951 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol
Number of subjects: 48
Study 2869951 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg bisoprolol
Number of subjects: 48
Study 29939421 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycaemic clamp (5-6 mmol/l)
Number of subjects: 8
Study 29939421 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycaemic clamp (9-10 mmol/l)
Number of subjects: 8
Study 26214555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (10 mg daily)
Number of subjects: 130
Study 26214555 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (20 mg daily)
Number of subjects: 130
Study 26214555 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin and Valsartan combination (10 mg and 20 mg)
Number of subjects: 130
Study 26214555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 130
Study 24997178 — intervention group
Group type: EXPERIMENTAL
Intervention: MGDRx EyeBag (heated device)
Number of subjects: 25
Study 24997178 — intervention group
Group type: COMPARATOR
Intervention: Non-heated device (control)
Number of subjects: 25
Study 22230203 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephone follow-up
Number of subjects: 65
Study 22230203 — intervention group
Group type: COMPARATOR
Intervention: Hospital follow-up
Number of subjects: 65
Study 20046171 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 45
Study 20046171 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic therapy (UST)
Number of subjects: 45
Study 17912501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride 200 mg
Number of subjects: 10
Study 17912501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride 400 mg
Number of subjects: 10
Study 17912501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15868614 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 636
Study 15868614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 636
Study 12421850 — intervention group
Group type: EXPERIMENTAL
Intervention: [6S]-5-methyltetrahydrofolate (113 micro g/d)
Number of subjects: 104
Study 12421850 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (100 micro g/d)
Number of subjects: 104
Study 12421850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 10604083 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment responders (n=21)
Number of subjects: 28
Study 10604083 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely recovered responders (n=11)
Number of subjects: 28
Study 10604083 — intervention group
Group type: COMPARATOR
Intervention: Unimproved subjects (n=7)
Number of subjects: 28
Study 7561414 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 90
Study 7561414 — intervention group
Group type: COMPARATOR
Intervention: Pins and plaster
Number of subjects: 90
Study 7561414 — intervention group
Group type: COMPARATOR
Intervention: Both groups (external fixation and pins and plaster)
Number of subjects: 90
Study 2025165 — intervention group
Group type: EXPERIMENTAL
Intervention: CCC technique
Number of subjects: 40
Study 2025165 — intervention group
Group type: COMPARATOR
Intervention: Can opener technique
Number of subjects: 40
Study 2025165 — intervention group
Group type: COMPARATOR
Intervention: Linear capsulotomy technique
Number of subjects: 40
Study 2025165 — intervention group
Group type: COMPARATOR
Intervention: Capsulopuncture technique
Number of subjects: 40
Study 6988785 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced protein‐calorie supplementation
Number of subjects: 0
Study 6988785 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein supplementation
Number of subjects: 0
Study 6988785 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30286636 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision and primary closure
Number of subjects: 60
Study 30286636 — intervention group
Group type: COMPARATOR
Intervention: Limberg flap technique
Number of subjects: 60
Study 28017706 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 38
Study 28017706 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-kHz current
Number of subjects: 38
Study 28017706 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 38
Study 25834203 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous tocilizumab (TCZ‐SC) monotherapy, 162 mg every 2 weeks (q2w)
Number of subjects: 319
Study 25834203 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous tocilizumab (TCZ‐SC) monotherapy
Number of subjects: 319
Study 25834203 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tocilizumab (TCZ‐IV) monotherapy, 8 mg/kg every 4 weeks
Number of subjects: 319
Study 23570275 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical service center (TmSC) management of home monitoring (HM) data
Number of subjects: 55
Study 21300808 — intervention group
Group type: EXPERIMENTAL
Intervention: Bear-hug test at varying arm positions (ideal position, 10° superior, 10° inferior to the shoulder line)
Number of subjects: 20
Study 21300808 — intervention group
Group type: EXPERIMENTAL
Intervention: Belly-press test at varying arm positions (ideal position, maximum shoulder external rotation, and maximal shoulder internal rotation)
Number of subjects: 20
Study 21300808 — intervention group
Group type: EXPERIMENTAL
Intervention: Lift-off test at varying arm positions (ideal position, hand position 5 in. [12.7 cm] superior and 5 in. [12.7 cm] inferior to the midlumbar spine)
Number of subjects: 20
Study 21300808 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison across the 3 tests (bear-hug, belly-press, lift-off)
Number of subjects: 20
Study 19433686 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐alpha‐2b
Number of subjects: 1256
Study 19433686 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1256
Study 17539986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg daily
Number of subjects: 582
Study 17539986 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily
Number of subjects: 582
Study 12774231 — intervention group
Group type: EXPERIMENTAL
Intervention: Four tasks resulting from a factorial combination of two types of judgment and two judgment-to-response mappings
Number of subjects: 0
Study 12774231 — intervention group
Group type: COMPARATOR
Intervention: Two tasks occurring in each block of trials
Number of subjects: 0
Study 11361054 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg for 24 days with simvastatin 40 mg on Days 15-24
Number of subjects: 2
Study 11361054 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg for 10 days
Number of subjects: 2
Study 11361054 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg for 24 days with simvastatin 80 mg on Days 15-24
Number of subjects: 2
Study 11361054 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 80 mg for 10 days
Number of subjects: 2
Study 9624541 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin (400 mg)
Number of subjects: 12
Study 9624541 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg)
Number of subjects: 12
Study 9624541 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg)
Number of subjects: 12
Study 8033544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% SLG solution
Number of subjects: 15
Study 8033544 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% surfactant mixture solutions (M1, M2, M3)
Number of subjects: 15
Study 8033544 — intervention group
Group type: COMPARATOR
Intervention: M1 (75/25 SLG/SLS)
Number of subjects: 15
Study 8033544 — intervention group
Group type: COMPARATOR
Intervention: M2 (50/50 SLG/SLS)
Number of subjects: 15
Study 8033544 — intervention group
Group type: COMPARATOR
Intervention: M3 (25/75 SLG/SLS)
Number of subjects: 15
Study 8033544 — intervention group
Group type: COMPARATOR
Intervention: 1% SLS solution
Number of subjects: 15
Study 2480029 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 200/0.5 10% with exercise
Number of subjects: 75
Study 2480029 — intervention group
Group type: COMPARATOR
Intervention: Ringer lactate with exercise
Number of subjects: 75
Study 2480029 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 75
Study 241306 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 6
Study 241306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31580310 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental manoeuvre (passive contralateral knee mobilization into extension)
Number of subjects: 38
Study 31580310 — intervention group
Group type: COMPARATOR
Intervention: Placebo manoeuvre
Number of subjects: 38
Study 31580310 — intervention group
Group type: COMPARATOR
Intervention: Control manoeuvre
Number of subjects: 38
Study 27986412 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 26
Study 27986412 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 26
Study 26210908 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief asthma education plus motivational interviewing counseling
Number of subjects: 165
Study 26210908 — intervention group
Group type: COMPARATOR
Intervention: Asthma education alone (Control)
Number of subjects: 165
Study 24236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of power perception in the out-group (the USA)
Number of subjects: 0
Study 24236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of perceived harmony of intergroup interests
Number of subjects: 0
Study 24236382 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 21443416 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic fermented milk (500 ml daily containing at least 5 × 10(7) CFU/ml of Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5, and Bifidobacterium lactis Bb12)
Number of subjects: 64
Study 21443416 — intervention group
Group type: COMPARATOR
Intervention: Acidified milk (equal volume to probiotic fermented milk)
Number of subjects: 64
Study 18205759 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation program
Number of subjects: 124
Study 18205759 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study 18205759 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study 16611288 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000 (0.50 g/kg)
Number of subjects: 67
Study 16611288 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (1.5 g/kg)
Number of subjects: 67
Study 14666025 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 60
Study 14666025 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60
Study 14666025 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 60
Study 14666025 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid and Aprotinin
Number of subjects: 60
Study 11062279 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency medical services (EMS) arrival
Number of subjects: 1207
Study 11062279 — intervention group
Group type: EXPERIMENTAL
Intervention: Total delay time (symptom onset until CT scan completion)
Number of subjects: 1207
Study 11062279 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from symptom onset to ED arrival
Number of subjects: 1207
Study 11062279 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from ED arrival until CT scan completion
Number of subjects: 1207
Study 9007165 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil
Number of subjects: 25
Study 9007165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 1508765 — intervention group
Group type: EXPERIMENTAL
Intervention: Mason suture technique
Number of subjects: 57
Study 1508765 — intervention group
Group type: COMPARATOR
Intervention: Reinforced continuous six-strand suture technique
Number of subjects: 57
Study 6356319 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g qid)
Number of subjects: 29
Study 6356319 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (300 mg qid)
Number of subjects: 29
Study 31490310 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous sutures (CS)
Number of subjects: 0
Study 31490310 — intervention group
Group type: COMPARATOR
Intervention: Interrupted sutures (IS)
Number of subjects: 0
Study 30478975 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented usual care and additional nurse support (Intervention)
Number of subjects: 95
Study 30478975 — intervention group
Group type: COMPARATOR
Intervention: Augmented usual care (Control)
Number of subjects: 95
Study 26588357 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant placement (IMP)
Number of subjects: 120
Study 26588357 — intervention group
Group type: COMPARATOR
Intervention: Fixed partial denture (FPD)
Number of subjects: 120
Study 26118315 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib
Number of subjects: 519
Study 26118315 — intervention group
Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 519
Study 24934242 — intervention group
Group type: EXPERIMENTAL
Intervention: mini‐cardiopulmonary bypass (mCPB)
Number of subjects: 26
Study 24934242 — intervention group
Group type: COMPARATOR
Intervention: conventional cardiopulmonary bypass (cCPB)
Number of subjects: 26
Study 24934242 — intervention group
Group type: EXPERIMENTAL
Intervention: Both mCPB and cCPB
Number of subjects: 26
Study 22933495 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumpatellar electrocautery (diathermy)
Number of subjects: 200
Study 22933495 — intervention group
Group type: COMPARATOR
Intervention: Control (no circumpatellar electrocautery)
Number of subjects: 200
Study 19152545 — intervention group
Group type: EXPERIMENTAL
Intervention: Objects associated with feelings of effort during goal pursuit
Number of subjects: 0
Study 19152545 — intervention group
Group type: COMPARATOR
Intervention: Objects associated with feelings of ease
Number of subjects: 0
Study 17064857 — intervention group
Group type: EXPERIMENTAL
Intervention: lofexidine + naloxone
Number of subjects: 137
Study 17064857 — intervention group
Group type: COMPARATOR
Intervention: lofexidine + placebo
Number of subjects: 137
Study 17064857 — intervention group
Group type: COMPARATOR
Intervention: methadone
Number of subjects: 137
Study 15125846 — intervention group
Group type: EXPERIMENTAL
Intervention: Single caudal epidural injection of 20 ml containing bupivacaine and tramadol
Number of subjects: 82
Study 15125846 — intervention group
Group type: COMPARATOR
Intervention: Single caudal epidural injection of 20 ml of normal saline
Number of subjects: 82
Study 11555126 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI) for 6 months
Number of subjects: 16
Study 11555126 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 16
Study 9856165 — intervention group
Group type: EXPERIMENTAL
Intervention: Human albumin
Number of subjects: 0
Study 9856165 — intervention group
Group type: COMPARATOR
Intervention: Withholding albumin or administration of crystalloid fluids
Number of subjects: 0
Study 8185469 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients (45 years old or younger)
Number of subjects: 1353
Study 8185469 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients older than 45 years but 65 years old or younger
Number of subjects: 1353
Study 8185469 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients older than 65 years
Number of subjects: 1353
Study 8185469 — intervention group
Group type: COMPARATOR
Intervention: Age considered in a Cox's multivariate model
Number of subjects: 1353
Study 3237594 — intervention group
Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB) with 7% citric acid
Number of subjects: 8
Study 3237594 — intervention group
Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB) with water
Number of subjects: 8
Study 3237594 — intervention group
Group type: COMPARATOR
Intervention: Citric acid alone
Number of subjects: 8
Study 3237594 — intervention group
Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB)
Number of subjects: 8
Study 29432045 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional economic incentive of R300 cash (∼$23) for starting ART within 3 months
Number of subjects: 86
Study 29432045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentive)
Number of subjects: 86
Study 27342383 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g of TXA intraoperative, followed by another postoperative
Number of subjects: 240
Study 27342383 — intervention group
Group type: EXPERIMENTAL
Intervention: 2g preoperative
Number of subjects: 240
Study 27342383 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 240
Study 24731899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) for headache pain management, 8-week duration
Number of subjects: 21
Study 24731899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 21
Study 23727917 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 3 µg
Number of subjects: 54
Study 23727917 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 54
Study 21130942 — intervention group
Group type: EXPERIMENTAL
Intervention: CCMIC (microincisional cataract surgery)
Number of subjects: 37
Study 21130942 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 37
Study 17179023 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula (28% more protein than standard formula)
Number of subjects: 299
Study 17179023 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 299
Study 15180118 — intervention group
Group type: EXPERIMENTAL
Intervention: P-NMES
Number of subjects: 15
Study 11230831 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous myocardial laser revascularization (PMR)
Number of subjects: 40
Study 9502454 — intervention group
Group type: EXPERIMENTAL
Intervention: piperacillin-tazobactam (TAZ; 4 g/0.5 g q.i.d.) + amikacin (7.5 mg/kg b.i.d.)
Number of subjects: 204
Study 9502454 — intervention group
Group type: COMPARATOR
Intervention: ceftazidime (CAZ; 1 g q.i.d.) + amikacin (7.5 mg/kg b.i.d.)
Number of subjects: 204
Study 8310997 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt enriched with Bifidobacterium longum and 5 g lactulose/L (A)
Number of subjects: 12
Study 8310997 — intervention group
Group type: COMPARATOR
Intervention: Conventional yogurt (B)
Number of subjects: 12
Study 3402355 — intervention group
Group type: EXPERIMENTAL
Intervention: urapidil 120 mg once daily
Number of subjects: 36
Study 3402355 — intervention group
Group type: COMPARATOR
Intervention: urapidil 60 mg twice daily
Number of subjects: 36
Study 28947166 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening of elbow and wrist flexors/extensors
Number of subjects: 20
Study 28947166 — intervention group
Group type: COMPARATOR
Intervention: Passive joint mobilization (control group)
Number of subjects: 20
Study 28947166 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening
Number of subjects: 20
Study 28947166 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole sample
Number of subjects: 20